Welcome to LookChem.com Sign In|Join Free
  • or
(+/-)-Ethyl 3-amino-2-(2-chlorophenyl)propanoate is a chemical compound with the molecular formula C11H14ClNO2. It is a chiral molecule, meaning it exists in two non-superimposable mirror-image forms, known as enantiomers. (+/-)-ethyl 3-amino-2-(2-chlorophenyl)propanoate is an amino acid derivative, specifically a substituted proline, and features a 2-chlorophenyl group attached to the propanoate chain. It is used in the synthesis of various pharmaceuticals and biologically active molecules due to its unique structure and potential to form stable chiral centers. The compound's properties, such as its reactivity and solubility, can be influenced by the presence of the chlorine atom and the amino group, making it a versatile building block in organic chemistry and drug development.

4251-58-5

Post Buying Request

4251-58-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4251-58-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4251-58-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,2,5 and 1 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4251-58:
(6*4)+(5*2)+(4*5)+(3*1)+(2*5)+(1*8)=75
75 % 10 = 5
So 4251-58-5 is a valid CAS Registry Number.

4251-58-5Relevant academic research and scientific papers

SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF

-

, (2020/02/14)

The present application relates to novel substituted N-arylethyl-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use there

Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Beck, Hartmut,Thaler, Tobias,Meibom, Daniel,Meininghaus, Mark,J?ri?en, Hannah,Dietz, Lisa,Terjung, Carsten,Bairlein, Michaela,Von Bühler, Clemens-Jeremias,Anlauf, Sonja,Fürstner, Chantal,Stellfeld, Timo,Schneider, Dirk,Gericke, Kersten M.,Buyck, Thomas,Lovis, Kai,Münster, Uwe,Anlahr, Johanna,Kersten, Elisabeth,Levilain, Guillaume,Marossek, Virginia,Kast, Raimund

, p. 11639 - 11662 (2020/11/26)

Idiopathic pulmonary fibrosis (IPF) is a rare and devastating chronic lung disease of unknown etiology. Despite the approved treatment options nintedanib and pirfenidone, the medical need for a safe and well-tolerated antifibrotic treatment of IPF remains

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4251-58-5